Mindset Pharma Files Patent for Quickest, Cheapest Method to Synthesize Psilocybin
“Based on our research, we think we’re able to get to psilocybin in fewer steps than any of the other published methods,” says the company’s CEO.
Day: August 3, 2021
Australia’s First Psychedelic Research Institute Opens with $40 Million Investment
Psychae Institute will collaborate with other clinical research organizations to develop novel psychedelic medicines and accompanying psychotherapeutic treatment models.
End of content
End of content